- Home
- CPRX vs CDP Comparison
CPRX vs CDP Comparison
Compare CPRX & CDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- CDP
- Stock Information
- Founded
- CPRX 2002
- CDP 1988
- Country
- CPRX United States
- CDP United States
- Employees
- CPRX N/A
- CDP N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- CDP Real Estate Investment Trusts
- Sector
- CPRX Health Care
- CDP Real Estate
- Exchange
- CPRX Nasdaq
- CDP Nasdaq
- Market Cap
- CPRX 2.9B
- CDP 3.3B
- IPO Year
- CPRX 2006
- CDP N/A
- Fundamental
- Price
- CPRX $20.78
- CDP $27.90
- Analyst Decision
- CPRX Strong Buy
- CDP Buy
- Analyst Count
- CPRX 6
- CDP 6
- Target Price
- CPRX $32.83
- CDP $33.50
- AVG Volume (30 Days)
- CPRX 1.4M
- CDP 880.2K
- Earning Date
- CPRX 08-06-2025
- CDP 07-28-2025
- Dividend Yield
- CPRX N/A
- CDP 4.36%
- EPS Growth
- CPRX 178.13
- CDP N/A
- EPS
- CPRX 1.57
- CDP 1.24
- Revenue
- CPRX $534,645,999.00
- CDP $748,556,000.00
- Revenue This Year
- CPRX $16.37
- CDP N/A
- Revenue Next Year
- CPRX $8.80
- CDP $5.84
- P/E Ratio
- CPRX $13.34
- CDP $22.49
- Revenue Growth
- CPRX 29.97
- CDP 5.34
- 52 Week Low
- CPRX $15.34
- CDP $23.92
- 52 Week High
- CPRX $26.58
- CDP $34.22
- Technical
- Relative Strength Index (RSI)
- CPRX 38.36
- CDP 54.30
- Support Level
- CPRX $20.62
- CDP $27.88
- Resistance Level
- CPRX $22.10
- CDP $28.50
- Average True Range (ATR)
- CPRX 0.60
- CDP 0.45
- MACD
- CPRX 0.06
- CDP -0.03
- Stochastic Oscillator
- CPRX 50.34
- CDP 74.85
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About CDP COPT Defense Properties of Beneficial Interest
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.